Latest Capital Expansion News

International Graphite is advancing Australia’s first commercial graphite micronising plant at Collie, targeting commissioning by mid-2027. The facility promises a diverse range of superfine graphite products and potential annual EBITDA up to AUD 14.2 million based on current market conditions.

Westgold Resources outlines a $100 million brownfields expansion to raise Meekatharra processing capacity to 2.9Mtpa, aiming to add 47,000 ounces of annual gold production by FY28 and lift project NPV by up to $1.6 billion at spot gold prices.

Cryosite Limited delivered robust FY26 results with revenue up 18% to $16.7 million and net profit rising 19%, underpinned by a strategic warehouse acquisition that doubled storage capacity and a cool room expansion.

Amaero Inc. capped FY2026 with a record A$18.1 million revenue, expanded its production capacity, and landed a A$6.5 million US Department of War contract to develop alternative refractory alloy powders.

The Alternative Investment Trust (AIQ) posted a 2.0% diluted NTA return in 2025, weighed down by an 8% appreciation of the Australian dollar against its largely USD-denominated portfolio. The trust bolstered its capital base with a A$34.5 million rights issue and increased exposure to the WSS Master Fund.

Infratil Limited has issued nearly 2.8 million new ordinary shares under its Dividend Reinvestment Plan at an issue price of NZD 14.70 each, expanding its capital base without altering shareholder rank.

Centuria Capital Group has successfully secured $265 million through institutional placement and entitlement offers, setting the stage for a $35 million retail entitlement offer to follow.

Almonty Industries has announced a $700 million convertible senior notes offering due 2031, aiming to refinance existing debt and fund corporate initiatives amid rising tungsten demand.

EQ Resources has secured board approval for a A$39 million expansion at its Mt Carbine tungsten mine, aiming to double crushing capacity and boost annual production by 500 tonnes amid strong tungsten prices.

AFT Pharmaceuticals posted a 22% revenue jump to NZ$254.7 million and a 39% increase in operating profit to a record NZ$24.4 million for FY26, exceeding guidance. The company targets over NZ$300 million revenue for FY27, fueled by international expansion and a deepening R&D pipeline.

Catalyst Metals has identified a capital-efficient path to increase throughput at its Plutonic Mill by refurbishing a dormant processing circuit, enhancing flexibility for its ambitious plan to double annual gold production to around 200,000 ounces.

Ora Banda Mining has significantly expanded its gold resources and reserves at Waihi and Round Dam, while greenlighting a $375 million new mill and Waihi Underground development as part of its DRIVE to 300 growth plan.